These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 37651432

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Microarray patch for HIV prevention and as a multipurpose prevention technology to prevent HIV and unplanned pregnancy: an assessment of potential acceptability, usability, and programmatic fit in Kenya.
    Gachigua SG, Karuga R, Ngunjiri A, Jarrahian C, Coffey PS, Kilbourne-Brook M, Otiso L.
    Front Reprod Health; 2023; 5():1125159. PubMed ID: 37168102
    [Abstract] [Full Text] [Related]

  • 3. A qualitative study to explore daily versus on-demand oral pre-exposure prophylaxis (PrEP) in young people from South Africa, Uganda and Zimbabwe.
    Dietrich JJ, Ahmed N, Tshabalala G, Wu M, Mulaudzi M, Hornschuh S, Atujuna M, Muhumuza R, Ssemata AS, Stranix-Chibanda L, Nematadzira T, Bekker LG, Martinson N, Seeley J, Fox J.
    PLoS One; 2023; 18(6):e0287627. PubMed ID: 37384792
    [Abstract] [Full Text] [Related]

  • 4. Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment.
    Minnis AM, Atujuna M, Browne EN, Ndwayana S, Hartmann M, Sindelo S, Ngcwayi N, Boeri M, Mansfield C, Bekker LG, Montgomery ET.
    J Int AIDS Soc; 2020 Jun; 23(6):e25528. PubMed ID: 32544303
    [Abstract] [Full Text] [Related]

  • 5. Perspectives of South African youth in the development of an implant for HIV prevention.
    Krogstad EA, Atujuna M, Montgomery ET, Minnis A, Ndwayana S, Malapane T, Shapley-Quinn MK, Manenzhe K, Bekker LG, van der Straten A.
    J Int AIDS Soc; 2018 Aug; 21(8):e25170. PubMed ID: 30152004
    [Abstract] [Full Text] [Related]

  • 6. Preferences for oral PrEP dosing among adolescent boys and young men in three sub-Saharan African countries.
    Kakande A, Ssemata AS, Muhumuza R, Atujuna M, Abaasa A, Ndekezi D, Tshabalala G, Nematadzira T, Hornschuh S, Nomvuyo M, Ahmed N, Maluadzi M, Anne Weiss H, Webb E, Stranix-Chibanda L, Janine Dietrich J, Seeley J, Fox J.
    PLoS One; 2023 Aug; 18(10):e0285132. PubMed ID: 37812644
    [Abstract] [Full Text] [Related]

  • 7. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study.
    Mack N, Evens EM, Tolley EE, Brelsford K, Mackenzie C, Milford C, Smit JA, Kimani J.
    J Int AIDS Soc; 2014 Aug; 17(3 Suppl 2):19157. PubMed ID: 25224616
    [Abstract] [Full Text] [Related]

  • 8. "Killing two birds with one stone" - a qualitative study on women's perspectives on the dual prevention pill in Johannesburg, South Africa.
    Tenza S, Mampuru L, Moji M, Zulu S, Begg L, Bruce IV, Reddy K, Friedland BA, Palanee-Phillips T, Mathur S.
    BMC Womens Health; 2024 Aug 22; 24(1):462. PubMed ID: 39174929
    [Abstract] [Full Text] [Related]

  • 9. Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.
    Atujuna M, Newman PA, Wallace M, Eluhu M, Rubincam C, Brown B, Bekker LG.
    PLoS One; 2018 Aug 22; 13(2):e0191251. PubMed ID: 29420549
    [Abstract] [Full Text] [Related]

  • 10. Health Care Worker Perspectives of HIV Pre-exposure Prophylaxis Service Delivery in Central Uganda.
    Muwonge TR, Nsubuga R, Ware NC, Wyatt MA, Pisarski E, Kamusiime B, Kasiita V, Nalukwago GK, Brown C, Nakyanzi A, Bagaya M, Bambia F, Ssebuliba T, Katabira E, Kyambadde P, Baeten JM, Heffron R, Celum C, Mujugira A, Haberer JE.
    Front Public Health; 2022 Aug 22; 10():658826. PubMed ID: 35444979
    [Abstract] [Full Text] [Related]

  • 11. Oral pre-exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study.
    Mayanja Y, Kamacooko O, Lunkuse JF, Muturi-Kioi V, Buzibye A, Omali D, Chinyenze K, Kuteesa M, Kaleebu P, Price MA.
    J Int AIDS Soc; 2022 May 22; 25(5):e25909. PubMed ID: 35543110
    [Abstract] [Full Text] [Related]

  • 12. [Current status of the female condom in Africa].
    Deniaud F.
    Sante; 1997 May 22; 7(6):405-15. PubMed ID: 9503499
    [Abstract] [Full Text] [Related]

  • 13. Implants for HIV prevention in young women: Provider perceptions and lessons learned from contraceptive implant provision.
    Humphries H, Upfold M, Mahlase G, Mdladla M, Gengiah TN, Abdool Karim Q.
    PLoS One; 2022 May 22; 17(1):e0262043. PubMed ID: 35025908
    [Abstract] [Full Text] [Related]

  • 14. Acceptability of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) during Pregnancy in Malawi, South Africa, Uganda, and Zimbabwe.
    Young AM, Stoner MCD, Mathebula F, Mohuba R, Baez A, Seyama L, Mutero P, Etima J, Fabiano Z, Fairlie L, Mayo AJ, Balkus JE, Song M, Bunge K, Piper J, Balan IC, van der Straten A, Montgomery ET.
    AIDS Behav; 2024 Nov 22; 28(11):3615-3628. PubMed ID: 39052199
    [Abstract] [Full Text] [Related]

  • 15. End-user research in support of long-acting systemic antiretroviral delivery systems: insights from qualitative research with providers and target users in South Africa.
    Brown MS, Hanif H, Little KM, Clark MR, Thurman AR, Flomen L, Doncel GF.
    BMC Infect Dis; 2022 Dec 08; 22(1):919. PubMed ID: 36482336
    [Abstract] [Full Text] [Related]

  • 16. Prospective acceptability of a multipurpose technology (MPT) implant in preclinical development to prevent HIV and unplanned pregnancy: Qualitative insights from women end users and health care providers in South Africa and Zimbabwe.
    Nkomo S, Makoni W, Shapley-Quinn MK, Luecke E, Mbatsane E, Manenzhe K, Ahmed K, Johnson LM, Mahaka I, van der Straten A.
    PLoS One; 2023 Dec 08; 18(5):e0285711. PubMed ID: 37195918
    [Abstract] [Full Text] [Related]

  • 17. Influences on willingness to use vaginal or oral HIV PrEP during pregnancy and breastfeeding in Africa: the multisite MAMMA study.
    van der Straten A, Ryan JH, Reddy K, Etima J, Taulo F, Mutero P, Taylor J, Piper J, Musara P, MTN-041/MAMMA Study Team.
    J Int AIDS Soc; 2020 Jun 08; 23(6):e25536. PubMed ID: 32524700
    [Abstract] [Full Text] [Related]

  • 18. HIV self-testing and oral pre-exposure prophylaxis are empowering for sex workers and their intimate partners: a qualitative study in Uganda.
    Mujugira A, Nakyanzi A, Kasiita V, Kamusiime B, Nalukwago GK, Nalumansi A, Twesigye CC, Muwonge TR, Baeten JM, Wyatt MA, Haberer JE, Ware NC.
    J Int AIDS Soc; 2021 Sep 08; 24(9):e25782. PubMed ID: 34473405
    [Abstract] [Full Text] [Related]

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 20. Policymakers' and healthcare providers' perspectives on the introduction of oral pre-exposure prophylaxis for key populations in Ghana.
    Nagai H, Adiibokah E, Tagoe H, Tun W, Pilgrim NA, Ankomah A, Rahman YAA, Addo SA, Atuahene SK, Essandoh E, Maher S, Kowalski M.
    BMC Public Health; 2023 Jun 05; 23(1):1065. PubMed ID: 37277772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.